Latest news
VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:46 GMTVERAXA Biotech (NASDAQ: VRXA) Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform - USA TodayUSA Today · Tue, 04 Aug 2026 04:28:55 GMTVERAXA Biotech (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform - TradingViewTradingView · Thu, 30 Jul 2026 17:04:34 GMTVERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTVERAXA Biotech (NASDAQ: VRXA) Shareholders Approve Corporate Governance, Financing Measures - TradingViewTradingView · Tue, 28 Jul 2026 16:36:58 GMT